SECURITIES AND EXCHANGE COMMISSION
Washington D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934
March 2, 2005
(Date of Report)
(Date of earliest event reported)
JOHN WILEY & SONS, INC.
(Exact name of registrant as specified in its charter)
New York
(State or jurisdiction of incorporation)
0-11507 13-5593032
- -------------------------------------- ----------------------------------
Commission File Number IRS Employer Identification Number
111 River Street, Hoboken NJ 07030
- -------------------------------------- ----------------------------------
Address of principal executive offices Zip Code
Registrant's telephone number, including area code: (201) 748-6000
--------------
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):
[ ] Written communications pursuant to Rule 425 under the Securities Act(17
CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act(17
CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act(17 CFR 240.13e-4(c))
NOT APPLICABLE
This is the first page of a three-page document.
Item 5.02 Departure of Directors or Principal Officers
--------------------------------------------
On March 2, 2005, John Wiley and Sons, Inc ("the Company")
announced that Henry A. McKinnell, a non-executive director, has
chosen not to stand for re-election to the Board at the Annual
Meeting of Shareholders on September 15, 2005, but will serve out
his term until then. Dr. McKinnell, who is Chairman of the Board
and Chief Executive Officer of Pfizer, Inc., has served on the
Company's Board since 1996 and has been Chairman of the
Compensation Committee since September 2000.
The Company is initiating a search for Dr. McKinnell's
replacement.
Signature
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
John Wiley & Sons, Inc.
/S/ William J. Pesce
---------------------------------
William J. Pesce
President and Chief Executive Officer